Ultresa 23,000 UNT / 46,000 UNT / 46,000 UNT Delayed Release Oral Capsule
RxNorm 1245771
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1245771 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Ultresa 23,000 UNT / 46,000 UNT / 46,000 UNT Delayed Release Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Amylase 46000 UNT / lipase 23000 UNT / protease 46000 UNT Delayed Release Oral Capsule [Ultresa]
(Atom ID: 12361219)
SY
Synonym (SY):
Ultresa (amylase 46,000 UNT / protease 46,000 UNT / lipase 23,000 UNT) Delayed Release Oral Capsule
(Atom ID: 11845922)
SY
Synonym (SY):
Ultresa (amylases 46,000 UNT / endopeptidases 46,000 UNT / lipase 23,000 UNT) Delayed Release Oral Capsule
(Atom ID: 11845923)
PSN